Sinovac Biotech

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate

Retrieved on: 
星期五, 九月 2, 2022
Court, LLC, Review, Capital, Annual Meetings of the International Monetary Fund and the World Bank Group, Person, Complaint, GLOBE, Annual general meeting, NASDAQ, Security (finance), Insurance, Sinovac Biotech

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA

Retrieved on: 
星期四, 九月 1, 2022
Titan, TO, Rights, NASDAQ, Time, Globe, WHY, Ownership, Class, Disclosure, LinkedIn, Court, GLOBE, Company, Twitter, Capital, LLC, Facebook, THE, Advertising, I-Space (Chinese company), Family, Insurance, Tobacco, Security (finance), Sinovac Biotech

WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate

Retrieved on: 
星期五, 八月 26, 2022
Legal, Professional Services, Court, LLC, Review, Capital, NUALS Arts and Literary Annual Meet, Person, Complaint, Annual general meeting, NASDAQ, Security (finance), Insurance, Sinovac Biotech

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

SINOVAC BIOTECH LTD. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts

Retrieved on: 
星期四, 八月 25, 2022
Trigger, Securities Exchange Act of 1934, Telephone, Rights, District court, NASDAQ, Date, Lists of schools in England, Ownership, Sinovac Biotech, Class, Board, Disclosure, Agreement, SEC, Indian stock exchange, District, Complaint, GLOBE, Company, Business, Acquisition, Security (finance), Practice of law

The filed Complaint alleges that in opposition to the Yin Group, 1Globe and Li and other Defendants, undertook a fraudulent plan to disenfranchise other shareholders.

Key Points: 
  • The filed Complaint alleges that in opposition to the Yin Group, 1Globe and Li and other Defendants, undertook a fraudulent plan to disenfranchise other shareholders.
  • On March 28, 2016, Sinovac adopted the Rights Agreement that contained a poison pill designed to prevent parties other than the Yin Group from taking control of Sinovac.
  • The Rights Agreement has been amended seven times, is still in effect and set to expire on February 22, 2023.
  • The SEC Order states that Li was opposed to the Rights Agreement because he believed it would discourage rivals bids for the Company.

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate

Retrieved on: 
星期二, 八月 23, 2022
Court, LLC, Review, Capital, Annual Meetings of the International Monetary Fund and the World Bank Group, Person, Complaint, GLOBE, Annual general meeting, NASDAQ, Security (finance), Insurance, Sinovac Biotech

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/sva .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA

Retrieved on: 
星期六, 八月 20, 2022
Titan, TO, Rights, NASDAQ, Time, Globe, WHY, Ownership, Class, Disclosure, LinkedIn, Court, Company, Twitter, Capital, LLC, Facebook, THE, Advertising, I-Space (Chinese company), Family, Tobacco, Insurance, Security (finance), Sinovac Biotech

WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SVA Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their Sinovac Biotech Ltd. Losses for Securities Class Action Against 1Globe Capital LLC and Certain of its Officers

Retrieved on: 
星期六, 八月 20, 2022
Court, GLOBE, Rights, Learning, SAN, NASDAQ, LLP, Ridesharing company, Tobacco, Sinovac Biotech

The Sinovac class action lawsuit seeks to represent holders of Sinovac Biotech Ltd. (NASDAQ: SVA) stock who sold their shares between April 11, 2016 and February 22, 2019 (the Class Period).

Key Points: 
  • The Sinovac class action lawsuit seeks to represent holders of Sinovac Biotech Ltd. (NASDAQ: SVA) stock who sold their shares between April 11, 2016 and February 22, 2019 (the Class Period).
  • Investors are hereby notified that they have until October 17, 2022 to move the Court to serve as lead plaintiff in this action.
  • An investor's ability to share any potential future recovery of the Sinovac class action lawsuit is not dependent upon serving as lead plaintiff.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

SINOVAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm

Retrieved on: 
星期五, 八月 19, 2022
Class Action Lawsuit, Professional Services, Legal, Jeanne Eagels, Telephone, Securities Exchange Act of 1934, Rights, Exchange, District court, NASDAQ, Time, Ownership, Class, Person, Disclosure, Defendant, Court, Company, P.C, Family, Tobacco, Security (finance), Sinovac Biotech

Investors have until October 17, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 17, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Defendants are individuals and entities associated with 1Globe, a family investment office that is owned and controlled by Defendant Jiaqiang Li (Li).
  • Li was Sinovacs largest shareholder when 1Globes Chief Executive Officer made an offer in January 2016 to buy Sinovac for approximately $350 million.
  • While Plaintiff and the Class also seek to receive fair value if Sinovac is taken private, Defendants behind-the-scenes scheming impeded this effort.

EQUITY ALERT: Rosen Law Firm Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA

Retrieved on: 
星期三, 八月 17, 2022
Class Action Lawsuit, Professional Services, Legal, Titan, Disclosure, TO, Capital, Facebook, LLC, Advertising, Class, Court, Company, Family, Twitter, I-Space (Chinese company), Globe, Rights, WHY, NASDAQ, Exchange, Ownership, LinkedIn, Time, THE, Tobacco, Insurance, Security (finance), Sinovac Biotech

WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Pomerantz Law Firm Announces the Filing of a Class Action Against 1Globe Capital LLC and Certain Officers, on behalf of Shareholders of Sinovac Biotech Ltd. – SVA

Retrieved on: 
星期二, 八月 16, 2022
Disclosure, Lists of action films, Pomerantz, GLOBE, Capital, Securities Exchange Act of 1934, District, LLC, Defendant, Research, Class, Company, LLP, Court, Lists of schools in England, Ext, Family, Complaint, Vaccine, Rights, Exchange, NASDAQ, District court, Ownership, Time, Shareholder rights plan, Online gambling, Tobacco, Security (finance), Sinovac Biotech

Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Key Points: 
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Since January 2016, competing sets of shareholders have been vying for control of Sinovac.
  • Li was Sinovacs largest shareholders when 1Globes Chief Executive Officer made an offer in January 2016 to buy Sinovac for approximately $350 million.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.